Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Ranbaxy Agrees to Pay at Least $350 Million to Settle U.S. Suit

May 13 (Bloomberg) -- Ranbaxy Laboratories Ltd. agreed to pay at least $350 million to settle a whistle-blower lawsuit joined by the U.S. that alleges the company made false claims in connection federal drug program payments.

The agreement, which also reflected the company’s plan to plead guilty to related criminal charges, was filed in federal court in Maryland.

Link to Company News:{RBXY IN <Equity> CN <GO>}

To contact the reporter on this story: Andrew Zajac in Washington at

To contact the editor responsible for this story: Fred Strasser at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.